The Role of ddPCR™ Technology in Sensitive MRD Monitoring in Research Settings
MRD monitoring has evolved from early molecular assays to liquid biopsy approaches that detect tumor signals in blood or tissue. Because these signals are often present at extremely low levels, MRD research requires highly sensitive and reproducible quantification. By partitioning each sample into tens of thousands of individual droplets, Droplet Digital™ PCR (ddPCR) technology delivers the sensitivity and absolute quantification needed to detect rare targets that may fall at or below the quantification limits of conventional assays.
In this white paper, you will learn about:
- How MRD monitoring has evolved from early feasibility studies to today’s ctDNA-based approaches
- The expanding role of MRD in hematologic malignancies and solid-tumor research
- Why ddPCR technology is well suited for detecting and quantifying rare targets in research samples
- How ddPCR technology and next-generation sequencing can serve complementary roles
- What greater standardization and analytical rigor could mean for the future of MRD research
Download the White Paper
Share a little information with us to download the entire white paper now.